Integrity Continuing Education

 


 

SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & Fulvestrant for Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"

1,107 views
January 26, 2024
3 Comments
Login to view comments. Click here to Login
Oncology & Hematology